Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Revolution Medicines (RVMD) EPS (Weighted Average and Diluted): 2020-2024

Historic EPS (Weighted Average and Diluted) for Revolution Medicines (RVMD) over the last 5 years, with Dec 2024 value amounting to -$3.58.

  • Revolution Medicines' EPS (Weighted Average and Diluted) fell 71.28% to -$1.61 in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.18, marking a year-over-year decrease of 41.53%. This contributed to the annual value of -$3.58 for FY2024, which is 7.25% up from last year.
  • According to the latest figures from FY2024, Revolution Medicines' EPS (Weighted Average and Diluted) is -$3.58, which was up 7.25% from -$3.86 recorded in FY2023.
  • In the past 5 years, Revolution Medicines' EPS (Weighted Average and Diluted) registered a high of -$2.01 during FY2020, and its lowest value of -$3.86 during FY2023.
  • Over the past 3 years, Revolution Medicines' median EPS (Weighted Average and Diluted) value was -$3.58 (recorded in 2024), while the average stood at -$3.51.
  • Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first fell by 27.86% in 2021, then climbed by 7.25% in 2024.
  • Revolution Medicines' EPS (Weighted Average and Diluted) (Yearly) stood at -$2.01 in 2020, then declined by 27.86% to -$2.57 in 2021, then fell by 19.84% to -$3.08 in 2022, then dropped by 25.32% to -$3.86 in 2023, then grew by 7.25% to -$3.58 in 2024.